Keywords: Pepscan Thera, Crucell, Johnson & Johnson, Novel vaccines, Infectious diseases, M&A

Pepscan closes vaccines deal with Crucell; Update on J&J takeover

Article | 11 March 2011

Privately-held Dutch biotechnology firm Pepscan Therapeutics, which focuses on protein mimicry technology, has signed a research and license agreement with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Crucell

Pepscan Therapeutics

Johnson & Johnson

Go to company listing